Male circumcision: A globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections

Annual Review of Medicine

Volumn 65, Issue , 2014, Pages 293-306

  Tobian, Aaron A R ^a   Kacker, Seema ^a   Quinn, Thomas C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

AIDS; Bacterial vaginosis; Cervical cancer; Herpes simplex virus type 2 (HSV 2); Human papillomavirus (HPV)

Indexed keywords

CIRCUMCISION; COST CONTROL; HETEROSEXUAL MALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INSURANCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCALE UP; SEXUALITY; SEXUALLY TRANSMITTED DISEASE;

AFRICA SOUTH OF THE SAHARA; CIRCUMCISION, MALE; COST-BENEFIT ANALYSIS; CULTURE; DEVELOPING COUNTRIES; FEMALE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; INSURANCE COVERAGE; MALE; MEDICAID; PATIENT ACCEPTANCE OF HEALTH CARE; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SEXUALLY TRANSMITTED DISEASES, VIRAL; UNITED STATES;

EID: 84901500079     PISSN: 00664219     EISSN: 1545326X     Source Type: Book Series    
DOI: 10.1146/annurev-med-092412-090539     Document Type: Review

References (92)

1. World Health Organization, Joint United Nations Programme on HIV/AIDS. 2007. New data on male circumcision and HIV prevention: policy and programme implications. Conclusions and recommendations from WHO/UNAIDS Tech.Consult., Montreux, Mar. 6-8. http://data.unaids.org/pub/Report/2007/mc-recommendations- en.pdf
2. American Academy of Pediatrics Task Force on Circumcision. 2012. Male circumcision. Pediatrics 130:e756-85
3. World Health Organization, Joint United Nations Programme on HIV/AIDS, London School of Hygiene and Tropical Medicine. 2007. Male circumcision: global trends and determinants of prevalence, safety, and acceptability. http://www.who.int/hiv/pub/malecircumcision/globaltrends/en/
4. Gairdner D. 1949. The fate of the foreskin, a study of circumcision. BMJ 2:1433-37
5. Lee RB. 2005. Circumcision practice in the Philippines: community based study. Sex. Transm. Infect. 81:91 (Pubitemid 40222875)
6. Ku JH, Kim ME, Lee NK, et al. 2003. Circumcision practice patterns in South Korea: community based survey. Sex. Transm. Infect. 79:65-67 (Pubitemid 36237831)
7. Pang MG, Kim DS. 2002. Extraordinarily high rates of male circumcision in South Korea: history and underlying causes. BJU Int. 89:48-54 (Pubitemid 34117764)
8. Kim DS, Lee JY, Pang MG. 1999. Male circumcision: a South Korean perspective. BJU Int. 83(Suppl. 1):28-33 (Pubitemid 29150289)
9. Siegfried N, Muller M, Volmink J, et al. 2003. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst. Rev. CD003362
10. Gray RH, Kigozi G, Serwadda D, et al. 2007. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369:657-66
11. Bailey RC, Moses S, Parker CB, et al. 2007. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369:643-56 (Pubitemid 46281312)
12. Auvert B, Taljaard D, Lagarde E, et al. 2005. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2:e298
13. Gray R, Kigozi G, Kong X, et al. 2012. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS 26:609-15
14. Bailey RC, Moses S, Parker C, et al. 2008. The protective effect of male circumcision is sustained for at least 42 months: results from the Kisumu, Kenya trial. Presented at Int. AIDS Conf., XVII, Mexico City, Aug. 3-8. Abstr. THAC0501
15. Mehta S, Parker C, Ndinya-Achola J, et al. 2011. MMC is not protective against HSV-2 incidence but halves the risk of GUD incidence: results from the randomized trial ofMMCto reduce HIV in Kisumu, Kenya. Presented at Conf. Retroviruses and Opportunistic Infections, 18th, Boston. Abstr. 147LB
16. Tobian AA, Serwadda D, Quinn TC, et al. 2009. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N. Engl. J. Med. 360:1298-309
17. Tobian AAR, Charvat B, Ssempijja V, et al. 2009. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infections among men in Rakai, Uganda. J. Infect. Dis. 199:945-49
18. Sobngwi-Tambekou J, Taljaard D, Lissouba P, et al. 2009. Effect of HSV-2 serostatus on acquisition of HIV by youngmen: results of a longitudinal study in Orange Farm, South Africa. J. Infect. Dis. 199:958-64
19. Mehta SD, Moses S, Parker CB, et al. 2012. Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection. AIDS 26:1141-49
20. Schoen EJ, Oehrli M, Colby C, et al. 2000. The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics 105:E36
21. Castellsague X, Bosch FX, Munoz N, et al. 2002. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N. Engl. J. Med. 346:1105-12 (Pubitemid 34984600)
22. Baldwin SB, Wallace DR, Papenfuss MR, et al. 2003. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J. Infect. Dis. 187:1064-70 (Pubitemid 36399348)
23. Lajous M, MuellerN, Cruz-Valdez A, et al. 2005. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol. Biomarkers Prev. 14:1710-16 (Pubitemid 40995084)
24. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. 2009. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J. Infect. Dis. 199:14-19
25. Wilson LE, Gravitt P, Tobian AA, et al. 2013. Male circumcision reduces penile high-risk human papillomavirus viral load in a randomised clinical trial in Rakai, Uganda. Sex. Transm. Infect. 89:262-66
26. Gray RH, Serwadda D, Kong X, et al. 2010. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J. Infect. Dis. 201:1455-62
27. Tobian AA, Kigozi G, Gravitt PE, et al. 2012. Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in Rakai, Uganda. AIDS 26:1555-65
28. Tobian AA, Kong X, Gravitt PE, et al. 2011. Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda. Int. J. Cancer. J. Int. Cancer 129:2970-75
29. Serwadda D, WawerMJ, Makumbi F, et al. 2010. Circumcision ofHIV-infectedmen: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda. J. Infect. Dis. 201:1463-69
30. Sobngwi-Tambekou J, TaljaardD, Nieuwoudt M, et al. 2009. Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex. Transm. Infect. 85:116-20
31. Mehta SD, Moses S, Agot K, et al. 2009. Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya. J. Infect. Dis. 200:370-78
32. Mehta SD, Gaydos C, Maclean I, et al. 2012. The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya. Sex. Transm. Dis. 39:276-80
33. Drain PK, Halperin DT, Hughes JP, et al. 2006. Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect. Dis. 6:172
34. Brinton LA, Reeves WC, Brenes MM, et al. 1989. The male factor in the etiology of cervical cancer among sexually monogamous women. Int. J. Cancer. 44:199-203 (Pubitemid 19217201)
35. Wawer MJ, Tobian AA, Kigozi G, et al. 2011. Effect of circumcision ofHIV-negativemen on transmission of human papillomavirus toHIV-negativewomen: a randomised trial in Rakai, Uganda. Lancet 277:209-18
36. Davis MA, Gray RH, Grabowski MK, et al. 2013. Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda. Int. J. Cancer 133:1247-52
37. Tobian AA, Kong X, Wawer MJ, et al. 2011. Circumcision of HIV-infected men and transmission of human papillomavirus to female partners: analyses of data from a randomised trial in Rakai, Uganda. Lancet Infect. Dis. 11:604-12
38. Gray RH, Kigozi G, Serwadda D, et al. 2009. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am. J. Obstet. Gynecol. 200:42 e1-7
39. Liu CM, Hungate BA, Tobian AA, et al. 2013. Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. Mbio 4:e00076
40. Mehta SD, Green SJ, Maclean I, et al. 2012. Microbial diversity of genital ulcer disease in men enrolled in a randomized trial of male circumcision in Kisumu, Kenya. PLoS One 7:e38991
41. Tobian AA, Kigozi G, Redd AD, et al. 2012. Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. J. Infect. Dis. 205:486-90
42. Wawer MJ, Makumbi F, Kigozi G, et al. 2009. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet 374:229-37
43. Gray RH, Kiwanuka N, Quinn TC, et al. 2000. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 14:2371-81
44. Baeten JM, Donnell D, Kapiga SH, et al. 2010. Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples. AIDS 24:737- 44
45. Hallett TB, Alsallaq RA, Baeten JM, et al. 2011. Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex. Transm. Infect. 87:88-93
46. Warner L, Ghanem KG, Newman DR, et al. 2009. Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. J. Infect. Dis. 199:59-65
47. Nielson CM, SchiaffinoMK, Dunne EF, et al. 2009. Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J. Infect. Dis. 199:7-13
48. Lu B, Wu Y, Nielson CM, et al. 2009. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J. Infect. Dis. 199:362-71
49. Buchbinder SP, Vittinghoff E, Heagerty PJ, et al. 2005. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J. Acquir. Immune Defic. Syndr. 39:82-89 (Pubitemid 40617023)
50. Kreiss JK, Hopkins SG. 1993. The association between circumcision status and human immunodeficiency virus infection among homosexual men. J. Infect. Dis. 168:1404-8 (Pubitemid 23344898)
51. El Bcheraoui C, Greenspan J, Kretsinger K, et al. 2010. Rates of selected neonatal male circumcision-associated severe adverse events in the United States, 2007-2009. Presented at Int. AIDS Conf., XVIII, Vienna. Abstr. THAC0104
52. Millett GA, Ding H, Lauby J, et al. 2007. Circumcision status and HIV infection among Black and Latino men who have sex with men in 3 US cities. J. Acquir. Immune Defic. Syndr. 46:643-50 (Pubitemid 350191059)
53. Sanchez J, Sal YRVG, Hughes JP, et al. 2010. Male circumcision and risk of HIV acquisition among men who have sex with men. AIDS 25:519-23
54. Millett GA, Flores SA, Marks G, et al. 2008. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 300:1674-84
55. Lane T, Raymond HF, Dladla S, et al. 2009. Lower risk of HIV infection among circumcised MSM: results from the Soweto Men's Study. Presented at Int. AIDS Soc. Conf., Cape Town, South Africa
56. Gray RH, Serwadda D, Tobian AA, et al. 2009. Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: analyses from the Rakai trials. PLoS Med. 6:e1000187
57. Kigozi G, Wawer M, Ssettuba A, et al. 2009. Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS 23:2209-13
58. Szabo R, Short RV. 2000. How does male circumcision protect against HIV infection? BMJ 320:1592-94 (Pubitemid 30336097)
59. McCoombe SG, Short RV. 2006. Potential HIV-1 target cells in the human penis. AIDS 20:1491-95 (Pubitemid 44100209)
60. Gray RH, Bailey RC, Morris BJ. 2010. Keratinization of the adultmale foreskin and implications formale circumcision. AIDS 24:1381
61. Patterson BK, Landay A, Siegel JN, et al. 2002. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am. J. Pathol. 161:867-73 (Pubitemid 34988374)
62. Dinh MH, McRaven MD, Kelley Z, et al. 2010. Keratinization of the adultmale foreskin and implications for male circumcision. AIDS 24:899-906
63. Dinh MH, Hirbod T, Kigozi G, et al. 2012. No difference in keratin thickness between inner and outer foreskins from elective male circumcisions in Rakai, Uganda. PLoS One 7:e41271
64. Johnson KE, Redd AD, Quinn TC, et al. 2011. Effects of HIV-1 and HSV-2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda. J. Infect. Dis. 203:602-9
65. Johnson KE, Sherman ME, Ssempijja V, et al. 2009. Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda. AIDS 23:1807-15
66. Dinh M, Barry S, Anderson M, et al. 2009. HIV-1 interactions and infection in adult male foreskin explant cultures. Presented at Conf. Retroviruses and Opportunistic Infections, 16th. Abstr. 502
67. Fischetti L, Barry SM, Hope TJ, et al. 2009. HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS 23:319-28
68. UNAIDS. 2010. Scaling-Up Male Circumcision Programmes in the Eastern and Southern Africa Region: Country UpdateMeeting to Share Lessons, Explore Opportunities and Overcome Challenges to Scale-Up. Geneva: UNAIDS, Joint United Nations Prog. HIV/AIDS
69. UNAIDS. 2011. Joint Strategic Action Framework to Accelerate the Scale-Up of Voluntary Medical Male Circumcision for HIV Prevention in Eastern and Southern Africa: 2012-2016. Geneva: UNAIDS, Joint United Nations Prog. HIV/AIDS
70. UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention. 2009. Male circumcision for HIV prevention in high HIV prevalence settings: What can mathematical modelling contribute to informed decision making? PLoS Med. 6:e1000109
71. Njeuhmeli E, Forsythe S, Reed J, et al. 2011. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med. 8:e1001132
72. Uthman OA, Popoola TA, Uthman MM, et al. 2010. Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV inmen in sub-Saharan Africa: a systematic review. PLoS One 5:e9628
73. Kacker S, Frick KD, Quinn TC, et al. 2013. Financial implications of male circumcision scale-up for the prevention of HIV and other sexually transmitted infections in a sub-Saharan African community. Sex. Transm. Dis. 40:559-68
74. Sansom SL, Prabhu VS, Hutchinson AB, et al. 2010. Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males. PLoS One 5:e8723
75. Kacker S, Frick KD, Gaydos CA, et al. 2012. Costs and effectiveness of neonatal male circumcision. Arch. Pediatr. Adolesc. Med. 166:910-18
76. Schoen EJ, Colby CJ, Ray GT. 2000. Newborn circumcision decreases incidence and costs of urinary tract infections during the first year of life. Pediatrics 105:789-93 (Pubitemid 30219526)
77. Dickson KE, Tran NT, Samuelson JL, et al. 2011. Voluntary medical male circumcision: a framework analysis of policy and program implementation in eastern and southern Africa. PLoS Med. 8:e1001133
78. Auvert B, Marseille E, Korenromp EL, et al. 2008. Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One 3:e2679
79. Curran K, Njeuhmeli E, Mirelman A, et al. 2011. Voluntary medical male circumcision: strategies for meeting the human resource needs of scale-up in southern and eastern Africa. PLoS Med. 8:e1001129
80. WorldHealthOrganization. 2012. Use ofDevices for Adult Male Circumcision in Public Health HIV Prevention Programmes: Conclusions of the WHO Technical Advisory Group on Innovations in Male Circumcision. Geneva: World Health Organ. http://whqlibdoc.who.int/hq/2012/WHO-HIV-2012.4-eng.pdf
81. Bitega JP, Ngeruka ML, Hategekimana T, et al. 2011. Safety and efficacy of the PrePex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings. J. Acquir. Immune Defic. Syndr. 58:e127-34
82. Barone MA, Ndede F, Li PS, et al. 2011. The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J. Acquir. Immune Defic. Syndr. 57:e7-12
83. Westercamp N, Bailey RC. 2007. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav. 11:341-55 (Pubitemid 46570814)
84. Kong X, Kigozi G, Nalugoda F, et al. 2012. Assessment of changes in risk behaviors during 3 years of posttrial follow-up of male circumcision trial participants uncircumcised at trial closure in Rakai, Uganda. Am. J. Epidemiol. 176:875-85
85. Chinkhumba J, Godlonton S, Thornton R. 2012. Demand for medical male circumcision.Work. pap., Dep. Econ., Univ. Mich. http://ipl.econ.duke.edu/bread/ papers/working/335.pdf
86. Wise J. 2006. Demand for male circumcision rises in a bid to prevent HIV. Bull. World Health Organ. 84:509-11
87. Tobian AA, Gray RH. 2011. The medical benefits of male circumcision. JAMA 306:1479-80
88. Clark SJ, Kilmarx PH, Kretsinger K. 2011. Coverage of newborn and adult male circumcision varies among public and private US payers despite health benefits. Health Aff. 30:2355-61
89. Xu F, Markowitz LE, Sternberg MR, et al. 2007. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex. Transm. Dis. 34:479-84 (Pubitemid 46987955)
90. Centers for Disease Control and Prevention. 2011. Trends in in-hospital newborn male circumcision- United States, 1999-2010. Morb. Mortal. Wkly. Rep. 60:1167-68
91. Leibowitz AA, Desmond K, Belin T. 2009. Determinants and policy implications of male circumcision in the United States. Am. J. Public Health 99:138-45
92. Leibowitz AA, Desmond K. 2012. Infant male circumcision and future health disparities. Arch. Pediatr. Adolesc. Med. 166:962-63